Notice: Prescription Drug List (PDL): Vitamin D

The purpose of this Notice of Amendment is to notify that Health Canada has revised the listing of Vitamin D on the Prescription Drug List (PDL) to allow non-prescription status for products a) containing up to 62.5 µg or 2,500 International Units (IU)/dosage form for oral use; or b) with a maximum recommended daily oral intake of 2,500 IU. Only the Human part of the PDL was revised.

Données et ressources

Info additionnelle

Champ Valeur
Dernière modification avril 17, 2026, 21:53 (TU)
Créé le avril 17, 2026, 21:53 (TU)
criticality_level []
geographic_scope []
open_canada_collection publication
open_canada_date_published 2021-02-22 00:00:00
open_canada_keywords {"fr": ["avis de modification", "Liste des drogues sur ordonnance", "LPD", "Vitamine D"], "en": ["notice of amendment", "Prescription Drug List", "PDL", "Vitamine D"]}
open_canada_subject ["health_and_safety"]
sensitivity_level unrestricted
title_fr Avis: Liste des drogues sur ordonnance (LDO) : Vitamine D
update_frequency as_needed